{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:52:15Z","timestamp":1790617935381,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jcjo.2023.01.019","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T21:20:18Z","timestamp":1677878418000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of pentosan polysulfate patients for development of an alert and screening system for ophthalmic monitoring"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-7609","authenticated-orcid":false,"given":"Grant L.","family":"Hom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanche L.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-5236","authenticated-orcid":false,"given":"James H.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham C.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resya","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-038X","authenticated-orcid":false,"given":"Justin C.","family":"Muste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0785-9099","authenticated-orcid":false,"given":"Tyler E.","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais F.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7725-1631","authenticated-orcid":false,"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-0717","authenticated-orcid":false,"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2023.01.019_bib0001","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.juro.2011.10.040","article-title":"Comparison of an interstitial cystitis\/bladder pain syndrome clinical cohort with symptomatic community women from the RAND interstitial cystitis epidemiology study","volume":"187","author":"Konkle","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0002","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0003","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium\u2013associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0004","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3928\/23258160-20201202-01","article-title":"From bladder pain to blurry vision: pentosan polysulfate sodium and the development of a novel maculopathy","volume":"51","author":"Ramakrishnan","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0008","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.oret.2022.03.016","article-title":"Redefining the spectrum of pentosan polysulfate retinopathy: multimodal imaging findings from a cross-sectional screening study","volume":"6","author":"Dieu","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.oret.2019.08.006","article-title":"Choroidal neovascularization associated with pentosan polysulfate toxicity","volume":"4","author":"Mishra","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ICB.0000000000001013","article-title":"Pentosan polysulfate sodium\u2013induced pigmentary maculopathy with non-leaking cystoid macular edema successfully treated with anti-VEGF therapy","volume":"16","author":"De Larochelli\u00e8re","year":"2022","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0011","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2018.12.037","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793\u2013802)","volume":"126","author":"Greenlee","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0012","first-page":"1062","article-title":"Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging","volume":"61","author":"Christiansen","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.oret.2021.07.004","article-title":"Expanded clinical spectrum of pentosan polysulfate maculopathy: a Macula Society collaborative study","volume":"6","author":"Jain","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0014","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2022.07.015","article-title":"Pentosan polysulfate sodium\u2013associated maculopathy: early detection using OCT angiography and choriocapillaris flow deficit analysis","volume":"244","author":"Fogel Levin","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0016","unstructured":"Food and Drug Administration, Center for Drug Evaluation and Research. ELMIRON \u2013100 mg (pentosan polysulfate sodium) capsules prescribing information. Washington: FDA. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/020193s014lbl.pdf"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0017","unstructured":"Pentosan polysulfate maculopathy. EyeWiki [Internet]. Available at: https:\/\/eyewiki.aao.org\/Pentosan_Polysulfate_Maculopathy (accessed April 1, 2022)."},{"key":"10.1016\/j.jcjo.2023.01.019_bib0018","unstructured":"Shah R, Jain N. Pentosan polysulfate maculopathy. Retinal Physician [Internet]. 2019. Available at: www.retinalphysician.com\/issues\/2019\/september-2019\/pentosan-polysulfate-maculopathy (accessed July 1, 2022)."},{"key":"10.1016\/j.jcjo.2023.01.019_bib0019","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/OPTH.S285013","article-title":"Maculopathy secondary to pentosan polysulfate use: a single-center experience","volume":"15","author":"Kalbag","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0020","article-title":"Identification of patients with pentosan polysulfate sodium\u2013associated maculopathy through screening of the electronic medical record at an academic center","volume":"2020","author":"Higgins","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0021","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/AOG.0000000000003794","article-title":"Pentosan polysulfate\u2013associated macular disease in patients with interstitial cystitis","volume":"135","author":"Lyons","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.urology.2020.08.072","article-title":"Pentosan polysulfate maculopathy: what urologists should know in 2020","volume":"147","author":"Paredes Mogica","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5489\/cuaj.6401","article-title":"Possible drug-induced, vision-threatening maculopathy secondary to chronic pentosan polysulfate sodium (Elmiron) exposure","volume":"14","author":"Doiron","year":"2020","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijmedinf.2017.08.008","article-title":"Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients","volume":"107","author":"Zenziper Straichman","year":"2017","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0025","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1377\/hlthaff.2010.1111","article-title":"Clinical decision support systems could be modified to reduce \u201calert fatigue\u201d while still minimizing the risk of litigation","volume":"30","author":"Kesselheim","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0026","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1136\/amiajnl-2011-000743","article-title":"Focus on clinical research informatics: evaluating alert fatigue over time to EHR-based clinical trial alerts: findings from a randomized controlled study","volume":"19","author":"Embi","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0027","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jamia\/ocy073","article-title":"Primary care provider adherence to an alert for intensification of diabetes blood pressure medications before and after the addition of a \u201cchart closure\u201d hard stop","volume":"25","author":"Ramirez","year":"2018","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0028","doi-asserted-by":"crossref","first-page":"e22013","DOI":"10.2196\/22013","article-title":"Reducing alert fatigue by sharing low-level alerts with patients and enhancing collaborative decision making using blockchain technology: scoping review and proposed framework (MedAlert)","volume":"22","author":"Wan","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjqs-2017-007737","article-title":"EHR-related alert fatigue: minimal progress to date, but much more can be done","volume":"28","author":"Payne","year":"2019","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0039-3402715","article-title":"Reducing alert burden in electronic health records: state of the art recommendations from four health systems","volume":"11","author":"McGreevey","year":"2020","journal-title":"Appl Clin Inform"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0031","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4338\/ACI-2017-01-RA-0003","article-title":"Electronic health record alert\u2013related workload as a predictor of burnout in primary care providers","volume":"8","author":"Gregory","year":"2017","journal-title":"Appl Clin Inform"},{"key":"10.1016\/j.jcjo.2023.01.019_bib0032","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T14:51:02Z","timestamp":1729090262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418223000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0008418223000418"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.01.019","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of pentosan polysulfate patients for development of an alert and screening system for ophthalmic monitoring","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}